drugset / Trial / NCT01615874
Study of the Effect of Mometasone Furoate/Formoterol (MF/F), Montelukast and Beclomethasone Dipropionate (BDP) on Plasma Cortisol Levels of Children 5-11 Years Old With Persistent Asthma (P05574)
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to assess the effect of one of five possible study medications used in the treatment of asthma on blood plasma cortisol levels in children aged 5-11 years with persistent asthma.
Timeline
- Start
- 2013-01
- Primary completion
- 2013-09
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Formoterol | Other / unclassified | 5 ug | Inhaled |
| Subject | Mometasone furoate | Other / unclassified | 25 ug | Inhaled |
| Subject | Mometasone furoate | Other / unclassified | 50 ug | Inhaled |
| Subject | Mometasone furoate | Other / unclassified | 100 ug | Inhaled |
| Comparator | Montelukast | Other / unclassified | 4 mg | Oral |
| Comparator | Montelukast | Other / unclassified | 5 mg | Oral |
| Comparator | beclomethasone dipropionate | Other / unclassified | 80 ug | Inhaled |
| Background | Prednisolone | Other / unclassified | — | — |
| Background | Prednisone | Other / unclassified | — | — |
| Background | Salbutamol | Unknown | 90 ug | Inhaled |
| Background | Salbutamol | Unknown | 100 ug | Inhaled |